Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02645916Phase 4Completed
Phase 4, randomised trial in Cold urticaria (CU) comparing DSGOST with Placebo (2 arms). Primary endpoint: Visual Analogue Scale at 6 weeks. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02645916.